Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Drug Free Solution, Inc. (DSOL)

0.0002
0.0000
(0.00%)
At close: April 25 at 4:00:00 PM EDT
Loading Chart for DSOL
  • Previous Close 0.0000
  • Open 0.0002
  • Bid 0.0002 x --
  • Ask 0.1000 x --
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0002 - 0.0002
  • Volume 35,000
  • Avg. Volume 0
  • Market Cap (intraday) 88,891
  • Beta (5Y Monthly) -0.95
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. Its Living Breath Process is a three-step process that combines self-analysis, breath, and language addressing various markets, including addiction/prevention, self help, emotional wellness, and lifestyle. The company also offers the Living Breath Series of programs with products, education, and services. Its Living Breath Project, through protocols, lifestyle enhancement products, training, and education, focuses on creating community wellness centers, wellness homes, and correctional facility support networks and centers that combine various offerings to diminish addiction and incarceration rates in the United States. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. Drug Free Solution, Inc. is based in El Segundo, California.

www.drugfreesolution.com

--

Full Time Employees

May 31

Fiscal Year Ends

Recent News: DSOL

View More

Performance Overview: DSOL

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DSOL
0.00%
S&P 500 (^GSPC)
6.06%

1-Year Return

DSOL
0.00%
S&P 500 (^GSPC)
9.44%

3-Year Return

DSOL
98.82%
S&P 500 (^GSPC)
28.61%

5-Year Return

DSOL
99.86%
S&P 500 (^GSPC)
94.77%

Compare To: DSOL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DSOL

View More

Valuation Measures

Annual
As of 2/18/2025
  • Market Cap

    88.89k

  • Enterprise Value

    88.89k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1,270.07%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.1k

  • Net Income Avi to Common (ttm)

    -867.71k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.12k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -195.44k

Research Analysis: DSOL

View More

Company Insights: DSOL

Research Reports: DSOL

View More

People Also Watch